Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L S Steelman

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Oncogene|November 1, 1993
Retroviral infection can abrogate the factor-dependency of hematopoietic cells by autocrine and non-autocrine mechanisms depending on the presence of a functional viral oncogeneJ A McCubrey, S R Smith, P A Algate, et al.
Leukemia|June 24, 2000
Combined effects of aberrant MEK1 activity and BCL2 overexpression on relieving the cytokine dependency of human and murine hematopoietic cellsW L Blalock, P W Moye, F Chang, et al.
Blood|November 15, 1991
Differential effect of phorbol esters and interleukin-3 on protein kinase C isoform content and kinase activity in the FDC-P1 cell lineD K Ways, W Qin, R S Riddle, et al.
Oncogene|March 4, 2000
A conditionally-active form of MEK1 results in autocrine tranformation of human and mouse hematopoietic cellsW L Blalock, M Pearce, L S Steelman, et al.
Leukemia|March 1, 1996
Oncogenic effects of overexpression of the interleukin-3 receptor on hematopoietic cellsL S Steelman, P A Algate, W L Blalock, et al.
Blood|October 15, 1995
Synergy between AUUUA motif disruption and enhancer insertion results in autocrine transformation of interleukin-3-dependent hematopoietic cellsM W Mayo, X Y Wang, P A Algate, et al.
Leukemia|March 21, 2003
Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapyF Chang, J T Lee, P M Navolanic, et al.
Leukemia|July 2, 2003
Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic interventionF Chang, L S Steelman, J T Lee, et al.
Leukemia|September 13, 2003
Differential effects of kinase cascade inhibitors on neoplastic and cytokine-mediated cell proliferationJ G Shelton, P W Moye, L S Steelman, et al.
Leukemia|December 9, 1998
Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cellsJ A McCubrey, L S Steelman, P E Hoyle, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Oncogene|November 1, 1993
Retroviral infection can abrogate the factor-dependency of hematopoietic cells by autocrine and non-autocrine mechanisms depending on the presence of a functional viral oncogeneJ A McCubrey, S R Smith, P A Algate, et al.
Leukemia|June 24, 2000
Combined effects of aberrant MEK1 activity and BCL2 overexpression on relieving the cytokine dependency of human and murine hematopoietic cellsW L Blalock, P W Moye, F Chang, et al.
Blood|November 15, 1991
Differential effect of phorbol esters and interleukin-3 on protein kinase C isoform content and kinase activity in the FDC-P1 cell lineD K Ways, W Qin, R S Riddle, et al.
Oncogene|March 4, 2000
A conditionally-active form of MEK1 results in autocrine tranformation of human and mouse hematopoietic cellsW L Blalock, M Pearce, L S Steelman, et al.
Leukemia|March 1, 1996
Oncogenic effects of overexpression of the interleukin-3 receptor on hematopoietic cellsL S Steelman, P A Algate, W L Blalock, et al.
Blood|October 15, 1995
Synergy between AUUUA motif disruption and enhancer insertion results in autocrine transformation of interleukin-3-dependent hematopoietic cellsM W Mayo, X Y Wang, P A Algate, et al.
Leukemia|March 21, 2003
Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapyF Chang, J T Lee, P M Navolanic, et al.
Leukemia|July 2, 2003
Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic interventionF Chang, L S Steelman, J T Lee, et al.
Leukemia|September 13, 2003
Differential effects of kinase cascade inhibitors on neoplastic and cytokine-mediated cell proliferationJ G Shelton, P W Moye, L S Steelman, et al.
Leukemia|December 9, 1998
Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cellsJ A McCubrey, L S Steelman, P E Hoyle, et al.
Pageof 5